Home | Fact Sheet I Contact Us
 

I  About Us  l  Public Reporting  l  ACO Participants  l Medicare Participants l Contact Us

 
   
 
 
 

Physicians Collaborative Trust ACO LLC

1101 N. Lake Destiny Road, Suite 300

Maitland, Florida 32751

ACO Primary Contacts

Larry E. Jones, CEO

ljones@pct-aco.com

407-475-9213 x 504

Composition of ACO:
Florida Limited Liability Company formed to facilitate the collaboration of ACO professionals (primary care and specialty physicians) ACO is NOT a partnership or in any joint venture arrangement with any hospital.

 

ACO Governing Body

  • Ajay Goyal, MD; Diagnostic Radiology Center of the Treasure Coast; ACO Provider/Supplier; Chairman; Voting Member
  • Charles Slattery, MD; South Titusville Medical Center, Inc.; ACO Participant; Voting Member
  • Armando Martinez, MD; Armando O. Martinez, MD, PA; ACO Participant; Voting Member
  • Jesus Gutierrez, MD; Gutierrez Medical Center, LLC; ACO Participant; Voting Member
  • Andrew Feldman, DO; Andrew C. Feldman, DO, PA; ACO Participant; Voting Member
  • Laura Hitchcock, MD; Hitchcock Health Institute; ACO Participant; Voting Member
  • Rodney Cable; Medicare Participant; Voting Member
  • Larry E. Jones, CEO, Physician Collabrative Trust ACO,LLC; Community Stakeholder; Voting Member
  • Mohammed Muqeem, MD; Hyderbad Medical Services, PLLC; ACO Participant; Voting Member
  • Frank Paiano, DO; Internal Medicine of Central Florida, P.A.; ACO Participant; Voting Member
  • Manjula Nayyar, MD; Pulmonary Medical Associates, P.A.;  ACO Participant; Voting Member
  • Humberto Dominguez, MD; Humberto A. Dominguez, M.D., P.A.; ACO Participant; Voting Member 

 

 

ACO Participant
  • Andrew C. Feldman, D.O., P.A.
  • Humberto A. Dominguez, M.D., P.A.
  • Internal Medicine of Central Florida, P.A.
  • Pulmonary Medical Associates, P.A.
  • Central Florida Primary Care
  • CFP Physicians Group
  • Peter Weissgerber, MD, PA
  • Gutierrez Medical Center, LLC
  • Hyderabad Medical Services, PLLC
  • CFP Care Team, LLC
  • South Titusville Medical Center
  • Moon Family Practice, LLC
  • Carlos L. Domingues, MD, PA
  • Hitchcock Health Institute
  • Armando O. Martinez, MD, PA

 

Physicians Collaborative Trust ACO LLC Committees
  • Compliance Committee: April Peterson
  • Quality Assurance Committee: Dr. Andrew Feldman, Dr. Akila Balasubramanian, Dr. Pedro Ortega
Key Clinical and Administrative Leadership Personnel
  • Larry Jones, CEO and ACO Executive
  • Ajay Goyal, MD, Board Chairman and Medical Director
  • April Peterson, Compliance Official
  • Ajay Goyal, MD, Quality Assurance/Improvement Officer
Shared Savings

Aggregate Amount of Shared Savings/Losses

  • Agreement period beginning 2013, Performance Year 1: $0
  • Agreement period beginning 2013, Performance Year 2014: $0
  • Agreement period beginning 2013, Performance Year 2015: $0

How Shared Savings Are Distributed

  • Agreement period beginning 2013, Performance Year 1: $0
  • Agreement period beginning 2013, Performance Year 2014: $0
  • Agreement period beginning 2013, Performance Year 2015: $0
 
 
 

Payment Rule Waivers

  • Reporting Waiver Use
  • No, our ACO does not utilize the SNF 3-Day rule waiver

Quality Performance Results

  2015 Reporting Period
Measure Number Measure Name Your ACO Performance Rate  Mean Performance Rate (SSP ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 79.59 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 90.27 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 88.54 91.94
ACO-4 CAHPS: Access to Specialists 83.94 83.61
ACO-5 CAHPS: Health Promotion and Education 61.87 59.06
ACO-6 CAHPS: Shared Decision Making 74.31 75.17
ACO-7 CAHPS: Health Status/Functional Status 75.79 72.30
ACO-34 CAHPS: Stewardship of Patient Resources 29.59 26.87
ACO-8 [3] Risk Standardized, All Condition Readmission 15.47 14.86
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 17.66 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 55.35 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 76.99 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 64.13 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 0.88 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.22 1.04
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 81.82% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record - 84.07%
ACO-13 Falls: Screening for Future Fall Risk 42.09% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization - 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 25.88% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up - 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention - 90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan - 45.25%
ACO-19 Colorectal Cancer Screening 24.39% 60.06%
ACO-20 Breast Cancer Screening - 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 77.86% 70.04%
ACO-40 Depression Remission at Twelve Months -- 6.11%
Diabetes Composite Diabetes Composite (All or Nothing Scoring) 11.11% 35.38%
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 44.44% 20.38%
ACO-41 Diabetes: Eye Exam 11.11% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 50.00% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 50.00% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 100.00% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 88.00% 77.73%
  

Quality Reporting 2013-2014

  2013 reporting period 2014 reporting period  
Measure Name Your ACO Performance Rate Mean Performance Rate (SSP ACOs) Your ACO Performance Rate Mean Performance Rate (SSP ACOs) Your ACO Performance Rate  Mean Performance Rate (SSP ACOs)
CAHPS: Getting Timely Care, Appointments, and Information Not in operations Not in operations Not in operations Not in operations 80.13 80.56%
CAHPS: How Well Your Providers Communicate Not in operations Not in operations Not in operations Not in operations 92.39 92.67%
CAHPS: Patients’ Rating of Provider Not in operations Not in operations Not in operations Not in operations 91.58 91.89%
CAHPS: Access to Specialists Not in operations Not in operations Not in operations Not in operations 83.97 84.08%
CAHPS: Health Promotion and Education Not in operations Not in operations Not in operations Not in operations 58.29 58.21%
CAHPS: Shared Decision Making Not in operations Not in operations Not in operations Not in operations 74.6 74.65%
CAHPS: Health Status/Functional Status Not in operations Not in operations Not in operations Not in operations 71.1 71.31%
Risk Standardized, All Condition Readmission Not in operations Not in operations Not in operations Not in operations 15.15 15.11%
Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) Not in operations Not in operations Not in operations Not in operations 1.08 1.03%
Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) Not in operations Not in operations Not in operations Not in operations 1.19 1.18%
Percent of PCPs who Successfully Meet Meaningful Use Requirements Not in operations Not in operations Not in operations Not in operations 76.71 80.46%
Medication Reconcilation Not in operations Not in operations Not in operations Not in operations 82.61 91.62%
Falls: Screening for Future Fall Risk Not in operations Not in operations Not in operations Not in operations 45.6 44.63%
Preventive Care and Screening: Influenza Immunization Not in operations Not in operations Not in operations Not in operations 57.51 58.16%
Pneumonia Vaccination Status for Older Adults Not in operations Not in operations Not in operations Not in operations 55.03 56.79%
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Not in operations Not in operations Not in operations Not in operations 77.75 67.86%
Preventive Care and Screening: Tobacco Use: Screening Not in operations Not in operations Not in operations Not in operations 86.79 91.24%
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan Not in operations Not in operations Not in operations Not in operations 39.27 36.66%
Colorectal Cancer Screening Not in operations Not in operations Not in operations Not in operations 56.14 57.72%
Breast Cancer Screening Not in operations Not in operations Not in operations Not in operations 61.41 62.98%
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented Not in operations Not in operations Not in operations Not in operations 60.24 58.97%
Hemoglobin A1c Control (HbA1c) Not in operations Not in operations Not in operations Not in operations 25.41 26.30%
Low Density Lipoprotein (LDL) (< 100 mg/dL) Not in operations Not in operations Not in operations Not in operations 48.9 26.30%
Blood Pressure (BP) < 140/90 Not in operations Not in operations Not in operations Not in operations 29.94 26.30%
Tobacco Non-Use Not in operations Not in operations Not in operations Not in operations 12.18 26.30%
Aspirin Use Not in operations Not in operations Not in operations Not in operations 25.9 26.30%
Diabetes Mellitus: Hemoglobin A1c Poor Control Not in operations Not in operations Not in operations Not in operations 20.35 17.83%
Hypertension: Controlling High Blood Pressure Not in operations Not in operations Not in operations Not in operations 68.02 69.39%
Percent of Participants with IVD with complete lipid profile and LDL control < 100mg/dl Not in operations Not in operations Not in operations Not in operations 57.29 58.78%
Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic Not in operations Not in operations Not in operations Not in operations 80.79 85.49%
Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) Not in operations Not in operations Not in operations Not in operations 82.71 87.72%
Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) Not in operations Not in operations Not in operations Not in operations 66.9 69.39
  
 
 
 
     Stay connected with us in your favorite flavor!  >>
       
 
 
    Copyright © 2011. All rights Reserved